Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,361 to 2,380 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma. | Br J Cancer | 2022 | 35249103 | PubTator, text mining | PubMed |
| Emodin relieves the inflammation and pyroptosis of lipopolysaccharide-treated 1321N1 cells by regulating methyltransferase-like 3 -mediated NLR family pyrin domain containing 3 expression. | Bioengineered | 2022 | 35246004 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine modification in pathogenesis of ischemic stroke. | Expert Rev Mol Diagn | 2022 | 35236212 | PubTator, text mining | PubMed |
| GAS5/METTL14/ESR1 genetic variants are related to the susceptibility of coronary heart disease. | Funct Integr Genomics | 2022 | 35235104 | PubTator, text mining | PubMed |
| Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis. | J Ovarian Res | 2022 | 35227296 | PubTator, text mining | PubMed |
| Role of N6-methyladenosine Modification in Cardiac Remodeling. | Front Cardiovasc Med | 2022 | 35224032 | PubTator, text mining | PubMed |
| N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma. | Front Mol Biosci | 2022 | 35223996 | PubTator, text mining | PubMed |
| Diagnostic, Therapeutic, and Prognostic Value of the m6A Writer Complex in Hepatocellular Carcinoma. | Front Cell Dev Biol | 2022 | 35223847 | PubTator, text mining | PubMed |
| Links Between N 6-Methyladenosine and Tumor Microenvironments in Colorectal Cancer. | Front Cell Dev Biol | 2022 | 35223837 | PubTator, text mining | PubMed |
| A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy. | Front Cell Dev Biol | 2022 | 35223835 | PubTator, text mining | PubMed |
| Construction and validation of a novel prognostic model for lung squamous cell cancer based on N6-methyladenosine-related genes. | World J Surg Oncol | 2022 | 35220962 | PubTator, text mining | PubMed |
| Dynamic control of chromatin-associated m6A methylation regulates nascent RNA synthesis. | Mol Cell | 2022 | 35219383 | PubTator, text mining | PubMed |
| FTO protects human granulosa cells from chemotherapy-induced cytotoxicity. | Reprod Biol Endocrinol | 2022 | 35219326 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability. | Exp Mol Med | 2022 | 35217832 | PubTator, text mining | PubMed |
| m6A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m6A-dependent manner. | Cell Death Discov | 2022 | 35217651 | PubTator, text mining | PubMed |
| Poly(rC)-Binding Protein 1 Limits Hepatitis C Virus Virion Assembly and Secretion. | Viruses | 2022 | 35215884 | PubTator, text mining | PubMed |
| Comparative Virus-Host Protein Interactions of the Bluetongue Virus NS4 Virulence Factor. | Viruses | 2022 | 35215776 | PubTator, text mining | PubMed |
| Construction of a lung adenocarcinoma prognostic model based on N6-methyl-adenosine-related long noncoding RNA and screening of potential drugs based on this model. | Anticancer Drugs | 2022 | 35213857 | PubTator, text mining | PubMed |
| Versatile functions of RNA m6A machinery on chromatin. | J Mol Cell Biol | 2022 | 35212732 | PubTator, text mining | PubMed |
| 29 m6A-RNA Methylation (Epitranscriptomic) Regulators Are Regulated in 41 Diseases including Atherosclerosis and Tumors Potentially via ROS Regulation - 102 Transcriptomic Dataset Analyses. | J Immunol Res | 2022 | 35211628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=119